Trial
NCT06508827
Intravenous Iron in Combination With Standard of Care Immunotherapy in Melanoma
Phase IIWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Indiana University
Collaborators
—
Condition
Anemia, Iron Deficiency
Intervention
Iron dextran 1000 mg IV
Why stopped
Difficulty recruiting participants
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2025-07-09